Title : THE RELATIONSHIP BETWEEN CD 74 LEVELS , MACROPHAGE MIGRATION INHIBITORY FACTOR GENE POLYMORPHISM AND CLINICAL FEATURES IN PATIENTS WITH ANKYLOSING SPONDYLITIS Running Title : Macrophage Migration Inhıbitory Factor and CD 74 In Ankylosing Spondylitis

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System.

  2017cited by this paper
• The biological function and significance of CD74 in immune diseases

  2017cited by this paper
• The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments

  2017cited by this paper
• Role of HLA-B27 in the pathogenesis of ankylosing spondylitis

  2017influential reference
• Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis

  2017cited by this paper
• Evaluation of MIF -173 G/C Polymorphism in Turkish Patients with Ankylosing Spondylitis.

  2016cited by this paper
• Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis

  2016cited by this paper
• Impact of gender, work, and clinical presentation on diagnostic delay in Italian patients with primary ankylosing spondylitis

  2016cited by this paper
• Genetics of ankylosing spondylitis—insights into pathogenesis

  2016cited by this paper
• Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk.

  2015cited by this paper
• The integral role of CD74 in antigen presentation, MIF signal transduction, and B cell survival and homeostasis.

  2014cited by this paper
• Advances in managing ankylosing spondylitis

  2014cited by this paper
• High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis

  2013cited by this paper
• Autoantibodies against CD74 in spondyloarthritis

  2013cited by this paper
• Association of macrophage migration inhibitory factor gene polymorphisms with Behçet's disease in a Han Chinese population.

  2012cited by this paper
• MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity

  2012cited by this paper
• Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.

  2011cited by this paper
• CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

  2011cited by this paper
• Genetics of ankylosing spondylitis

  2010cited by this paper
• Macrophage Migration Inhibitory Factor: A Multifunctional Cytokine in Rheumatic Diseases

  2010cited by this paper
• Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population.

  2009cited by this paper
• Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.

  2007cited by this paper
• Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.

  2005cited by this paper
• Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.

  2002cited by this paper
• Role of macrophage migration inhibitory factor (MIF) in murine antigen‐induced arthritis: interaction with glucocorticoids

  2001cited by this paper
• Annals of the New York Academy of Sciences Molecular Function of Macrophage Migration Inhibitory Factor and a Novel Therapy for Inflammatory Bowel Disease

  year unknowncited by this paper

• No citing papers are available for this paper.